Affordable Access

Dose and duration of fenfluramine-phentermine therapy impacts the risk of significant valvular heart disease.

Authors
Type
Published Article
Journal
The American Journal of Cardiology
0002-9149
Publisher
Elsevier
Publication Date
Volume
86
Issue
1
Pages
107–110
Identifiers
PMID: 10867106
Source
Medline
License
Unknown

Statistics

Seen <100 times